Overview

In this role, you will report to SVP, Oncology R&D Strategy, Business Development & Alliances and be accountable for the development and delivery of Therapeutic Area Strategy which may include a specific disease area and/or platform technology based on our latest priorities.

Responsibilities

• Develop and prioritize Oncology R&D portfolio strategy.
• Define and communicate clear strategic direction for near- and long-term growth across assets and platforms.
• Integrate clinical, scientific, and commercial insights to shape portfolio decisions and investment.
• Partner with internal and external stakeholders to deliver on high-impact strategic objectives.
• Advise executive senior leadership with clear, actionable insights and recommendations on complex strategic topics.
• Partner with leaders across clinical development, discovery, business development, and other key functions to create cohesive long-term strategies.
• Analyze internal and external data to identify trends, risks, and opportunities for portfolio growth and optimization.
• Foster a culture of collaboration, innovation, and accountability across all stakeholder groups.
• Ensure effective communication of strategy, progress, and priorities to diverse audiences, both internal and external.
• Demonstrate strategic mindset, analytical rigor, and people leadership to deliver positive outcomes on high-impact and complex strategic topics.

How you will operate

• Partner with leaders across clinical development, discovery, business development, and other key functions to create cohesive long-term strategies.
• Advise executive leadership with clear, actionable insights and recommendations on complex strategic topics.
• Analyze internal and external data to identify trends, risks, and opportunities for portfolio growth and optimization.
• Foster a culture of collaboration, innovation, and accountability across all stakeholder groups.
• Communicate strategy, progress, and priorities to diverse audiences—both internal and external.

Qualifications

• BA/BS with 10 years of experience in life sciences or consulting with a focus in life science programs OR MS/MBA with 8+ years of experience in life sciences or consulting with focus in life science programs OR PhD or MD with 5+ years of experience in life sciences or consulting with focus in life science programs.
• Deep understanding of Oncology Therapeutic Area Strategy which may include a specific disease area and/or platform technologies.
• Ability to interact and communicate effectively with senior executive teams.
• Demonstrated ability to lead and influence experienced professionals.
• Ability to think critically, creatively and to anticipate and solve problems.
• Ability to navigate and be successful in a fast-paced, highly-matrixed work environment.

Preferred Qualifications

• Strong analytical and communication skills.
• Effective interpersonal and relationship management skills with a consultative approach and ability to interact and build trust.
• Operational effectiveness, highly organized process with follow-through.
• Strong initiative to understand core business goals and establish processes or programs to set direction, generate alignment and push forward.
• Financial background and understanding of forecasts, budgets, financial activities and tools.
• Resourceful, motivated, influential and proactive; able to prioritize in a fast-growing organization.
• Experience in strategic planning processes and tools.
• Scientific background.
• Understanding of the pharmaceutical business (including R&D).
• Experience in translating business needs into a coordinated plan from a cross-functional senior leadership team.
• Ability to develop creative and simple solutions to complex problems.

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company and our innovative medicines are used by millions of patients worldwide. We are dedicated to being a Great Place to Work, where you are empowered to push the boundaries of science and unleash your entrepreneurial spirit. We are committed to lifelong learning, growth and development, and fostering an inclusive culture that champions diversity and collaboration.

Within Oncology R&D, we are empowered to be bold, take calculated risks and use our intelligence and courage to follow the science. We have delivered multiple oncology medicines and aim to continue expanding our pipeline, working with external partners and internal teams to drive innovation. We are moving to Kendall Square/Cambridge in 2026.